Results 201 to 210 of about 3,522,972 (323)

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Evaluation of data driven low-rank matrix factorization for accelerated solutions of the Vlasov equation. [PDF]

PLoS One
Jonnalagadda B, Becker S.
europepmc   +1 more source

1-forms with the exterior derivative of maximal rank [PDF]

, 1968
Tadashi Nagano
openalex   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Estimating the Number of Latent Ranks of the Fugl-Meyer Assessment Score for the Affected Upper Extremity After Stroke. [PDF]

Cureus
Hara K, Tauchi Y, Hanada K, Takebayashi T.   +3 more
europepmc   +1 more source

Rank for Nurses—and the ANA

, 1944
NULL AUTHOR_ID
openalex   +1 more source

The decomposability of torsion free modules of finite rank [PDF]

, 1968
Eben Matlis
openalex   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Research on Activation Mechanisms In Situ during Rapid Desorption of Mercury-Absorbing Activated Coke by the Heating Method

ACS Omega
Donghai An, Jiawei Zhao, Yanna Chen, Chunyan Bai, Xingxing Cheng   +4 more
doaj   +1 more source

Neural oscillation in low-rank SNNs: bridging network dynamics and cognitive function. [PDF]

Front Comput Neurosci
Li B, Zheng T, Otsuki R, Sugino M, Shimba K, Kotani K.   +5 more
europepmc   +1 more source